Related references
Note: Only part of the references are listed.Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Douglas G. Altman et al.
BMC MEDICINE (2012)
Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer
Xiaozhu Zhang et al.
International Journal of Medical Sciences (2012)
Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
Takayuki Kosaka et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Does the Epidermal Growth Factor Receptor Play a Role in the Progression of Thyroid Cancer?
Jeffrey A. Knauf
THYROID (2011)
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance
Rajiv Dua et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Epidermal Growth Factor Receptor Expression in Breast Cancer Association With Biologic Phenotype and Clinical Outcomes
Mothaffar F. Rimawi et al.
CANCER (2010)
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
V. Ludovini et al.
ANNALS OF ONCOLOGY (2009)
Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2γ Expression Levels Correlate With Basal Phenotype in Breast Cancer
Gulnur Guler et al.
CANCER (2009)
Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
Jean-Sebastien Guillamo et al.
CLINICAL CANCER RESEARCH (2009)
EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology
Sebastian Leibl et al.
APMIS (2008)
'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials
L. S. Kilburn
CLINICAL ONCOLOGY (2008)
Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma
Simon Florian Preuss et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor
Minoru Kogiku et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder
Xiaoyan Wang et al.
CLINICAL CANCER RESEARCH (2007)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike et al.
BREAST CANCER RESEARCH (2007)
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer
Paul N. Span et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Epithelial growth factor receptor status in primary and recurrent ovarian cancer
S Stadlmann et al.
MODERN PATHOLOGY (2006)
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1
BM Ryan et al.
ANNALS OF ONCOLOGY (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
D Xie et al.
BRITISH JOURNAL OF CANCER (2006)
Survivin study: An update of What is the next wave?
Fengzhi Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
Michel Zimmermann et al.
RADIATION ONCOLOGY (2006)
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway
Q Wang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2005)
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma
C Riva et al.
VIRCHOWS ARCHIV (2005)
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy
TA Buchholz et al.
CANCER (2005)
Impact of EGFR expression on colorectal cancer patient prognosis and survival
JP Spano et al.
ANNALS OF ONCOLOGY (2005)
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
BA Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Survivin is an independent prognostic marker for risk stratification of breast cancer patients
PN Span et al.
CLINICAL CHEMISTRY (2004)
Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome
AC Fields et al.
MODERN PATHOLOGY (2004)
Survivin expression in oral squamous cell carcinoma
L Lo Muzio et al.
BRITISH JOURNAL OF CANCER (2003)
Lack of prognostic significance of survivin, survivin-ΔEx3, survivin-2B, galectin-3, bag-1, bax-α and MRP-1 rnRNAs in breast cancer
L O'Driscoll et al.
CANCER LETTERS (2003)
Androgen receptor expression in estrogen receptor-negative breast cancer - Immunohistochemical, clinical, and prognostic associations
SN Agoff et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Prognostic importance of survivin in breast cancer
SM Kennedy et al.
BRITISH JOURNAL OF CANCER (2003)
Expression of survivin in astrocytic tumors - Correlation with malignant grade and prognosis
Y Kajiwara et al.
CANCER (2003)
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer
S Tsutsui et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
The molecular basis and potential role of survivin in cancer diagnosis and therapy
DC Altieri
TRENDS IN MOLECULAR MEDICINE (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
